Figures & data
Figure 1. Deconvoluted LCMS spectra of reduced, control and oxidized infliximab. (A) Fc; (B) LC; (C) Fd.
![Figure 1. Deconvoluted LCMS spectra of reduced, control and oxidized infliximab. (A) Fc; (B) LC; (C) Fd.](/cms/asset/79c8a4aa-ea8f-4eeb-b7b2-9d9e918776e7/kmab_a_1290753_f0001_b.gif)
Table 1. Comparison of experimental assignments versus computational predictions at 9% SASA cutoff.
Table 2. List of 11 false negatives in Fd and light chain.
Table 3. Peptide mapping MS2 analysis of selected samples with false negative occurrences.
Table 4. Methionine near the end of H3.